Press Resease

Respiratory Disease Testing Market (Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and other Tests) for Hospitals, Physician Offices and Clinical Laboratories: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Published Date: 29-Aug-2016 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-114 Status : Published

Global respiratory disease testing market to gain USD 3.1 Billion by 2021 and increases with CAGR 3.6% between 2016 and 2021.

Description

The report provides analysis and forecast for the respiratory disease testing market on a regional and global level. The study covers historic data of 2015 provided along with a forecast from 2016 to 2021 based on revenue (USD billion). The study provides restraints and drivers for the respiratory disease testing market coupled along with the impact they have on the demand over the forecast period. Moreover, the report also covers the analysis of opportunities present in the respiratory disease testing market on a global level.

With the objective to give the users of this report a complete and clear view on the respiratory disease testing market and to better understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the respiratory disease testing market has also been covered. The study provides with a comprehensive market attractiveness analysis, wherein product segments and end-user segments are based on their growth rate, market size, and general attractiveness.

The study provides a clear view on the respiratory disease testing market by segmenting the market based on end-user segment, product segment, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on product segment, the respiratory disease testing market has been segmented into imaging, spirometry, peak flow, blood gas, lung volume, and other tests. Based on the end-user segment, the respiratory disease testing market has been segmented into physician offices, hospitals, and clinical laboratories. The regional segmentation includes the current and forecast demand for Latin America, North America, Asia-Pacific, Europe, and the Middle East and Africa with its further bifurcation into major countries including Germany, France, UK, China, Japan, India, U.S. AND Brazil.

The report also includes comprehensive profiles of end players such as ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. GE Healthcare and others. The thorough description of players includes parameters such as company overview, business, financial overview, and recent developments of the company.

This report segments the global respiratory disease testing market as follows:

Global Respiratory Disease Testing Market: Product Segment Analysis

  • Lung Volume
  • Imaging
  • Spirometry
  • Peak Flow
  • Blood Gas
  • Other Tests

Global Respiratory Disease Testing Market: End-user Segment Analysis

  • Hospitals
  • Physician Offices
  • Clinical Laboratories

Global Respiratory Disease Testing Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Respiratory Disease Testing market, 2015 - 2021 (USD Billion)
    • 2.2. Global Respiratory Disease Testing market: Snapshot
  • Chapter 3. Respiratory Disease Testing – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value chain analysis
    • 3.3. Market drivers
      • 3.3.1. Increase in Prevalence of Respiratory Diseases
      • 3.3.2. Changing Lifestyle and Improvement in Medical Facilities
    • 3.4. Market restraints
      • 3.4.1. Low adoption rate of advanced spirometers and digital radiography systems
    • 3.5. Opportunities
      • 3.5.1. Huge Potential Presented by Emerging Markets in Asia-Pacific
    • 3.6. Porter’s five forces analysis
      • 3.6.1. Bargaining power of suppliers 3.6.2. Bargaining power of buyers
      • 3.6.3. Threat from new entrants
      • 3.6.4. Threat from new substitutes
      • 3.6.5. Degree of competition
    • 3.7. Market attractiveness analysis
      • 3.7.1. Market attractiveness analysis, by product segment
      • 3.7.2. Market attractiveness analysis, by end-user segment
      • 3.7.3. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Respiratory Disease Testing Market – Competitive Landscape
    • 4.1. Company market share, 2015 (Subject to data availability)
    • 4.2. Price trend analysis
  • Chapter 5. Global Respiratory Disease Testing Market – Product Segment Analysis
    • 5.1. Global Respiratory Disease Testing market: Product segment overview
      • 5.1.1. Global Respiratory Disease Testing market revenue share, by product segment, 2015 and 2021
    • 5.2. Lung Volume
      • 5.2.1. Global Lung Volume market , 2015 – 2021 (USD Billion)
    • 5.3. Imaging
      • 5.3.1. Global Imaging market, 2015 – 2021 (USD Billion)
    • 5.4. Spirometry
      • 5.4.1. Global Spirometry market, 2015 – 2021 (USD Billion)
    • 5.5. Peak Flow
      • 5.5.1. Global Peak Flow market, 2015 – 2021 (USD Billion)
    • 5.6. Blood Gas
      • 5.6.1. Global Blood Gas market, 2015 – 2021 (USD Billion)
    • 5.7. Others
      • 5.7.1. Global Other Tests market, 2015 – 2021 (USD Billion)
  • Chapter 6. Global Respiratory Disease Testing Market – End-user Segment Analysis
    • 6.1. Global Respiratory Disease Testing market: End-user segment overview
      • 6.1.1. Global Respiratory Disease Testing market revenue share, by End-user segment, 2015 and 2021
    • 6.2. Hospitals
      • 6.2.1. Global Hospitals market , 2015 – 2021 (USD Billion)
    • 6.3. Physician Offices
      • 6.3.1. Global Physician Offices market, 2015 – 2021 (USD Billion)
    • 6.4. Clinical Laboratories
      • 6.4.1. Global Clinical Laboratories market, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Respiratory Disease Testing Market – Regional Segment Analysis
    • 7.1. Global Respiratory Disease Testing Market: Regional Overview
      • 7.1.1. Global Respiratory Disease Testing Market Volume Share By Region, 2015 And 2021
    • 7.2. North America
      • 7.2.1. North America Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
      • 7.2.2. North America Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021, (USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.2.3.2. U.S. Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
      • 7.3.2. Europe Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
      • 7.3.3. UK
        • 7.3.3.1. UK Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.3.3.2. UK Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.3.4.2. France Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021, (USD Billion)
      • 7.3.5. Germany
        • 7.3.5.1. Germany Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.3.5.2. Germany Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021, (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
      • 7.4.2. Asia Pacific Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.4.3.2. China Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.4.4.2. Japan Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.4.5.2. India Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
      • 7.5.2. Latin America Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
        • 7.5.3.2. Brazil Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
    • 7.6. Middle East And Africa
      • 7.6.1. Middle East And Africa Respiratory Disease Testing Market Revenue, By Product, 2015 – 2021, (USD Billion)
      • 7.6.2. Middle East And Africa Respiratory Disease Testing Market Revenue, By End-User, 2015 – 2021 (USD Billion)
  • Chapter 8. Company Profile
    • 8.1. ndd Medical Technologies, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Carestream Health, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. SDI Diagnostics
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Nihon Kohden Corporation
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. CareFusion Corporation
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. Smiths Medical
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. COSMED
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. Perkin Elmer, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. Philips Healthcare
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Developments
    • 8.10. MGC Diagnostic Corporation
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Developments
    • 8.11. Futuremed America, Inc.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Developments
    • 8.12. GE Healthcare
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product Portfolio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Developments

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Respiratory Disease Testing market. Zion Research has collected and analyzed key data belong to the global Respiratory Disease Testing market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Respiratory Disease Testing across the world has been calculated through primary and secondary research.

Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Respiratory Disease Testing industry. Primary research makes up major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Respiratory Disease Testing market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The respiratory tract performs the function of inhaling oxygen from the atmosphere into the lungs, transferring of the oxygen to the blood, and exhaling carbon dioxide outside of the body. Breathing is usually habitual, controlled automatically by the respiratory center at the base of the brain. In addition, the respiratory system also helps to stabilize blood-alkaline balance (pH), remove toxic waste and regulates temperature. Respiratory diseases inhibit this usual operation of the respiratory system and are usually caused as a result of the inhalation of dangerous agents, smoking, and unhealthy lifestyles. Besides this other factors such as genetic factors, infections either indirectly or directly may also cause respiratory ailments. There are many disorders and infections of the respiratory system. Infections occur more commonly in the respiratory tract as compared to other organs in the body. The respiratory testing devices aid in detecting chronic or acute respiratory diseases; which is very necessary for the treatment to people with respiratory damages.

Respiratory tests such as spirometry, lung volume, peak flow test, imaging, blood gas test, and few other tests are used to diagnose the respiratory disease. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. More than 200 million people globally are suffering from asthma, and there have more than 3 million deaths worldwide due to COPD. Moreover, technological advancements and growing aged population would drive the global respiratory disease testing market. However, portable spirometers and low adoption rate of digital radiography may curb the growth of respiratory disease testing market during the forecast period. However, the budding market in Asia-Pacific can act as a potential opportunity for respiratory disease testing market during the forecast period.

Global Respiratory Disease Testing Market

Based on the type of the test, the global respiratory disease testing market has been segmented into imaging test, peak flow test, blood gas test, spirometry, lung volume test, and other tests. The imaging test segment holds the largest share of the global respiratory disease testing market. The dominance of the segment was mainly due to high demand for imaging tests, especially X-ray. In addition, doctors insist for these tests as they are considered the primary tests for diagnosis of respiratory diseases. While the spirometry test segment is projected to be the fastest growing segment during the forecast period due to its effectiveness and accurate diagnostic results in a short period of time. 

The global respiratory disease testing market is segmented into three major end-user segments i.e. physician offices, hospitals, and clinical laboratories. Hospitals hold the largest market share of respiratory disease testing market in 2015. Hospitals hold more than 50% share of global respiratory disease testing market. The segment dominated the market as most of the respiratory diagnostic instruments, particularly X-ray machines are mostly available in hospitals. Moreover, doctors favor in-house diagnostic tests for their patients in comparison to outside patients.

North America holds the largest market share for respiratory disease testing in 2015. The dominance of the region was primarily due to rise popularity of portable devices, increasing the prevalence of respiratory diseases and growing demand for home health care devices and services. The respiratory disease testing market in Asia-Pacific is expected to grow at the fastest growth rate during the forecast period. Latin America is projected to expand at a noticeable growth rate during the forecast period.

Major market players in this industry are ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. and GE Healthcare among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com